Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, providing promising breakthroughs throughout various clinical and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, extra dependable alternate for therapeutic